THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CLINICAL PRACTICS
Abstract
About the Authors
Yu. B. BelousovRussian Federation
M. V. Leonova
Russian Federation
L. L. Shteinberg
Russian Federation
I. F. Tischenkova
Russian Federation
A. V. Sokolov
Russian Federation
References
1. Гусев Е.И., Белоусов Ю.Б., Гехт А.Б., Бондарева И.Б., Соколов А.В., Тищенкова И.Ф. Лечение эпилепсии: рациональное дозирование антиконвульсантов. 2000; 203 с.
2. Евтушенко С.К., Иванова Н.Ю., Омельяненко А.А., Евтушенко И.С. Мониторинг уровня антиконвульсантов в крови как протокольная необходимость в контроле терапии больных эпилепсией. Международный неврологический журнал. 2008; 5 (21): 15-21.
3. Сергиенко В.И., Джеллифф Р., Бондарева И.Б. Прикладная фармакокинетика: основные положения и клиническое применение. М.: Издательство РАМН, 2003, 208 с.
4. Шнайдер Н.А., Дмитренко Д.В., Пилюгина М.С. Фармакогенетика антиэпилептических препаратов. Бюллетень сибирской медицины 2008; 4: 111-9.
5. Aldaz A., Ferriols R., Aumente D. et al. Pharmacokinetic Monitoring of Antiepileptic Drugs. Farm Hosp. 2011; 35: 326-39.
6. Baumann P., Hiemke C., Ulrich S. et. al. AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry. 2004; 37 (6): 243-65.
7. Babaei A., Eslamai M.H. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients. Int. J. Clin. Pharmacol. Ther. 2007; 45 (2): 121-5.
8. Brunton L.L., Chabner B.A., Knollmann B.C., Goodman & Gilman’s the Pharmacological Basis of Therapeutics. Pharmacotherapy of the Epilepsies, Valproic Acid. The McGraw-Hill Companies. 2011; 12e: Chapter 21.
9. Duncan J.S., Sander J.W., Sisodiya S.M., Walker M.C. Adult epilepsy. Lancet 2006; 367: 1087-1100.
10. Ghodke-Puranik Y., Thorn C.F., Lamba J.K. et al. Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenetics and genomics 2013; 23 (4): 236-41.
11. Irshaid Y.M., Hamdi A.A., Al Homrany M. Evaluation of therapeutic drug monitoring of antiepileptic drugs. Int. J. Clin. Pharmacol. Ther. 2003; 41 (3): 126-31.
12. Johannessen S.I., Landmark C.J. Value of therapeutic drug monitoring in epilepsy. Expert Rev. Neurother. 2008; 8 (6): 929-39.
13. Juvany R., Leiva E., Gasol M. et al. Safety of expanded therapeutic range of valproic acid. Eur. J. Hosp. Pharm. 2012; 19: 196-7.
14. Meng H., Ren J., Lv Y. et al. Association study of CYP3A5 genetic polymorphism with serum concentrations of carbamazepine in Chinese epilepsy patients. Neurology Asia. 2011; 16 (1): 39-45.
15. Neels H.M., Sierens A.C., Naelaerts K. et al. Therapeutic drug monitoring of old and newer antiepileptic drugs. Clin. Chem. Lab. Med. 2004; 42 (11): 1228-55.
16. Park P.W., Seo Y.H., Ahn J.Y. et al. Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients. J. Clin. Pharm. Ther. 2009; 34 (5): 569-74.
17. Patsalos P.N., Berry D.J., Bourgeois B.F. et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008; 49 (7): 1239-76.
18. Radeef M.Y., Al-Shamma К., Hammash B.M. Therapeutic drug monitoring and evaluation of therapeutic effectiveness and adverse effects of antiepileptic drugs in Iraqi epileptic patients. Glob. J. Med. Res. 2012; 12 (8): 11-34.
19. Saruwatari J., Ishitsu T., Nakagawa К. Update on the genetic polymorphisms of drug-metabolizing enzymes in antiepileptic drug therapy. Pharmaceuticals 2010;3:2709-32.
20. Shakya G., Malla S., Shakya K.N., Shrestha R. Therapeutic drug monitoring of antiepileptic drugs. J. Nepal. Med. Assoc. 2008; 47 (171): 94-7.
21. Seo T., Nakada N., Ueda N. et al. Effect of CYP3A5*3 on carbamazepine pharmacokinetics in Japanese patients with epilepsy. Clin. Pharmacol. Ther. 2006; 79 (5): 509-10.
22. Warner A., Privitera M., David B. Standards of laboratory practice: antiepileptic drug monitoring. Clinical Chemistry 1998; 44 (5): 1085-95.
Review
For citations:
Belousov Yu.B., Leonova M.V., Shteinberg L.L., Tischenkova I.F., Sokolov A.V. THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CLINICAL PRACTICS. Epilepsy and paroxysmal conditions. 2013;5(3):6-16. (In Russ.)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.